<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01389115</url>
  </required_header>
  <id_info>
    <org_study_id>Iul_LC</org_study_id>
    <nct_id>NCT01389115</nct_id>
  </id_info>
  <brief_title>Fatty Acids Lipidome and Oxidative Stress in Liver Transplantation</brief_title>
  <official_title>Fatty Acids Lipidome and Oxidative Stress Markers as Indicators of Liver Transplant Outcome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Roma La Sapienza</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Roma La Sapienza</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine lipid metabolism in chronic liver disease in the
      attempt to find a useful biomarker of liver function and of prognostic value of graft
      function in those patients who undergo liver transplant. The present study enrolls subjects
      with liver cirrhosis (with different ethiology), including subjects eligible for a full-size
      liver transplantation, and healthy controls.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Liver has a central role in fatty acids metabolism that is impaired in chronic liver
      diseases. Polyunsaturated fatty acids are reportedly reduced in liver cirrhosis, which is
      considered a condition of essential fatty acids deficiency. However, there is a paucity of
      data concerning the level of the multitude of circulating fatty acids in liver cirrhosis.
      Oxidative stress is involved in the pathogenesis of chronic liver disease and fibrosis.
      Increased oxidative stress with impaired antioxidant status at the systemic level has been
      described in different chronic liver diseases and negatively influences graft function after
      liver transplantation (Poli G. 2000, Loguercio C 2003). 7-Ketocholesterol and
      7beta-hydroxycholesterol, prototype molecules of free radical-mediated cholesterol oxidation,
      are very important oxysterols currently accepted as in vivo reliable markers of oxidative
      stress. High oxysterols plasma levels are associated with an alteration of normal plasma
      fatty acid pattern in cystic fibrosis (Iuliano 2009). The Model for End-Stage Liver Disease
      (MELD) score is a common score used routinely to stage liver function in patients with liver
      cirrhosis (Al Sibae 2010). After ischemia-reperfusion injury at liver transplantation
      oxidative stress, hepatic endoplasmic reticulum (ER) stress and cholesterol metabolism are
      interrelated key processes to preserve graft regeneration and function. A blood sample is
      obtained in each subject to measure MELD score at the first visit and at liver
      transplantation. Further blood samples are collected at days seven and 30 post
      transplantation. Blood samples are also obtained from healthy subjects. Liver biopsy samples
      are obtained from liver transplant donors. Oxidative stress and fatty acids lipidomics are
      measured to evaluate the actual plasma concentration in liver cirrhosis patients to be
      compared with healthy controls. Oxidative stress and fatty acids are also analyzed as a
      function of disease status, and for its influence on transplant outcomes. Lipid metabolism
      gene and endoplasmic stress reticulum gene expression are evaluated in liver biopsy specimen
      to study the influence on graft function.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2001</start_date>
  <completion_date type="Anticipated">September 2016</completion_date>
  <primary_completion_date type="Anticipated">May 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Post operative graft function after liver transplantation</measure>
    <time_frame>Change in graft function after 7 and 30 days after liver transplantation</time_frame>
    <description>â€¢ Multiple lipid metabolism biomarkers (fatty acids, cholesterol and oxysterols) are evaluated in the plasma of liver cirrhosis patients before liver transplantation. A logistic regression model is used to evaluate which of these biomarkers is an independent predictor of graft function</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Early gene expression in the liver graft</measure>
    <time_frame>30 days</time_frame>
    <description>Assessment of lipid metabolism-, oxidative stress-, and ER stress-gene expression in graft tissue liver tissue specimens of patients undergoing organ transplantation and their impact on graft function. Lipid metabolism and ER gene expression (genes: LDL-R, HMGCR, CD81, SREBP2, NPC1L1, XBP-1, XBP2, ATF6, GRP78, GRP94, LXR, INSIG1, INSIG2) in liver graft specimens at transplantation before and after ischemia-reperfusion injury; downregulated and upregulated genes are related to early graft function.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">320</enrollment>
  <condition>Liver Cirrhosis</condition>
  <arm_group>
    <arm_group_label>Liver Cirrhosis</arm_group_label>
    <description>Patient with liver cirrhosis undergoing liver transplant</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Liver donors</arm_group_label>
    <description>Subjects eligible for organ explant</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy controls</arm_group_label>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples and liver biopsy specimens
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        1. 150 cirrhotic patients, including Hepatocellular Carcinoma (HCC), Hepatitis C Virus
             (HCV) positive patients

          2. 80 healthy controls

          3. 100 liver donors
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Liver cirrhosis inclusion criteria:

          -  subjects with liver cirrhosis eligible for liver transplant, and one MELD score
             determination performed at least 3 months before liver transplantation

        Liver cirrhosis exclusion criteria:

          -  liver transplant contraindication and re-transplantation

          -  current use of antioxidants and fatty acids supplements

        Healthy controls are recruited recruited among the University personnel, after a review of
        their medical history.

        Exclusion criteria for control participants included the use of drugs that affect fatty
        acids (systemic corticosteroids, isotretinoin, and ursodiol) and/or oxidative stress
        (antioxidants and hypolipemic drugs).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefano Corradini, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sapienza University of Rome</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stefano Corradini, M.D., Ph.D.</last_name>
    <phone>+390649972086</phone>
    <email>stefano.corradini@uniroma1.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Clinical Medicine Division of Gastroenterology, Sapienza University of Rome</name>
      <address>
        <city>Rome</city>
        <state>RM</state>
        <zip>00161</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefano Corradini, M.D., Ph.D.</last_name>
      <phone>+39 06 4997</phone>
      <phone_ext>2086</phone_ext>
      <email>Stefano.Corradini@uniroma1.it</email>
    </contact>
    <contact_backup>
      <last_name>Antonio Molinaro, M.D.</last_name>
      <phone>+39 06 4997</phone>
      <phone_ext>2086</phone_ext>
      <email>antoniomolinaro83@libero.it</email>
    </contact_backup>
    <investigator>
      <last_name>Antonio Molinaro, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Liver Transplant Center Paride Stefanini, Sapienza University of Rome</name>
      <address>
        <city>Rome</city>
        <state>RM</state>
        <zip>00161</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Massimo Rossi, M.D.</last_name>
      <phone>+39 3346214536</phone>
      <email>massimo.rossi@uniroma1.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Laboratory of Vascular Medicine, Department of Medical Sciences and Biotechnology, Sapienza University of Rome</name>
      <address>
        <city>Latina</city>
        <zip>04100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luigi Iuliano, M.D.</last_name>
      <phone>+39 0773 471046</phone>
      <email>luigi.iuliano@uniroma1.it</email>
    </contact>
    <contact_backup>
      <last_name>Chiara Zerbinati, Ph.D.</last_name>
      <phone>+39 0773 471046</phone>
      <email>chiara.zerbinati@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Luigi Iuliano, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Chiara Zerbinati, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Poli G. Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med. 2000 Jun;21(3):49-98. Review.</citation>
    <PMID>10978499</PMID>
  </reference>
  <reference>
    <citation>Loguercio C, Federico A. Oxidative stress in viral and alcoholic hepatitis. Free Radic Biol Med. 2003 Jan 1;34(1):1-10. Review.</citation>
    <PMID>12498974</PMID>
  </reference>
  <reference>
    <citation>Iuliano L, Monticolo R, Straface G, Zullo S, Galli F, Boaz M, Quattrucci S. Association of cholesterol oxidation and abnormalities in fatty acid metabolism in cystic fibrosis. Am J Clin Nutr. 2009 Sep;90(3):477-84. doi: 10.3945/ajcn.2009.27757. Epub 2009 Jul 8.</citation>
    <PMID>19587087</PMID>
  </reference>
  <reference>
    <citation>Al Sibae MR, Cappell MS. Accuracy of MELD scores in predicting mortality in decompensated cirrhosis from variceal bleeding, hepatorenal syndrome, alcoholic hepatitis, or acute liver failure as well as mortality after non-transplant surgery or TIPS. Dig Dis Sci. 2011 Apr;56(4):977-87. doi: 10.1007/s10620-010-1390-3. Epub 2010 Sep 16. Review.</citation>
    <PMID>20844956</PMID>
  </reference>
  <results_reference>
    <citation>Corradini SG, Micheletta F, Natoli S, Iappelli M, Di Angelantonio E, De Marco R, Elisei W, Siciliano M, Rossi M, Berloco P, Attili AF, Diczfalusy U, Iuliano L. High preoperative recipient plasma 7beta-hydroxycholesterol is associated with initial poor graft function after liver transplantation. Liver Transpl. 2005 Dec;11(12):1494-504.</citation>
    <PMID>16258953</PMID>
  </results_reference>
  <results_reference>
    <citation>Iuliano L, Micheletta F, Natoli S, Ginanni Corradini S, Iappelli M, Elisei W, Giovannelli L, Violi F, Diczfalusy U. Measurement of oxysterols and alpha-tocopherol in plasma and tissue samples as indices of oxidant stress status. Anal Biochem. 2003 Jan 15;312(2):217-23.</citation>
    <PMID>12531208</PMID>
  </results_reference>
  <results_reference>
    <citation>Corradini SG, Elisei W, De Marco R, Siciliano M, Iappelli M, Pugliese F, Ruberto F, Nudo F, Pretagostini R, Bussotti A, Mennini G, Eramo A, Liguori F, Merli M, Attili AF, Muda AO, Natalizi S, Berloco P, Rossi M. Preharvest donor hyperoxia predicts good early graft function and longer graft survival after liver transplantation. Liver Transpl. 2005 Feb;11(2):140-51.</citation>
    <PMID>15666381</PMID>
  </results_reference>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 6, 2011</study_first_submitted>
  <study_first_submitted_qc>July 5, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 7, 2011</study_first_posted>
  <last_update_submitted>December 10, 2015</last_update_submitted>
  <last_update_submitted_qc>December 10, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 11, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Roma La Sapienza</investigator_affiliation>
    <investigator_full_name>Luigi Iuliano</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>liver cirrhosis</keyword>
  <keyword>oxidative stress</keyword>
  <keyword>liver transplant</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Extracts</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

